13-23335003-T-C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The NM_014363.6(SACS):​c.8873A>G​(p.Lys2958Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00422 in 1,613,794 control chromosomes in the GnomAD database, including 254 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K2958N) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.023 ( 143 hom., cov: 33)
Exomes 𝑓: 0.0023 ( 111 hom. )

Consequence

SACS
NM_014363.6 missense

Scores

1
8
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1B:10

Conservation

PhyloP100: 5.95

Publications

9 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Myriad Women's Health, Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Laboratory for Molecular Medicine, Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_014363.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0077159405).
BP6
Variant 13-23335003-T-C is Benign according to our data. Variant chr13-23335003-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 193711.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0772 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.8873A>Gp.Lys2958Arg
missense
Exon 10 of 10NP_055178.3
SACS
NM_001437336.1
c.8900A>Gp.Lys2967Arg
missense
Exon 11 of 11NP_001424265.1A0A804HIQ1
SACS
NM_001278055.2
c.8432A>Gp.Lys2811Arg
missense
Exon 8 of 8NP_001264984.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.8873A>Gp.Lys2958Arg
missense
Exon 10 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.2432-5519A>G
intron
N/AENSP00000406565.2H0Y6M8
SACS
ENST00000682944.1
c.8900A>Gp.Lys2967Arg
missense
Exon 11 of 11ENSP00000507173.1A0A804HIQ1

Frequencies

GnomAD3 genomes
AF:
0.0228
AC:
3476
AN:
152158
Hom.:
143
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0794
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00792
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.0215
GnomAD2 exomes
AF:
0.00587
AC:
1474
AN:
250928
AF XY:
0.00435
show subpopulations
Gnomad AFR exome
AF:
0.0788
Gnomad AMR exome
AF:
0.00365
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000463
Gnomad NFE exome
AF:
0.000423
Gnomad OTH exome
AF:
0.00311
GnomAD4 exome
AF:
0.00227
AC:
3316
AN:
1461518
Hom.:
111
Cov.:
37
AF XY:
0.00199
AC XY:
1448
AN XY:
727066
show subpopulations
African (AFR)
AF:
0.0787
AC:
2630
AN:
33430
American (AMR)
AF:
0.00418
AC:
187
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26118
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.000104
AC:
9
AN:
86246
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53404
Middle Eastern (MID)
AF:
0.00364
AC:
21
AN:
5766
European-Non Finnish (NFE)
AF:
0.000166
AC:
185
AN:
1111770
Other (OTH)
AF:
0.00462
AC:
279
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
200
400
600
800
1000
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
90
180
270
360
450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0229
AC:
3488
AN:
152276
Hom.:
143
Cov.:
33
AF XY:
0.0221
AC XY:
1645
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.0794
AC:
3301
AN:
41550
American (AMR)
AF:
0.00785
AC:
120
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
68004
Other (OTH)
AF:
0.0213
AC:
45
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
157
315
472
630
787
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00722
Hom.:
134
Bravo
AF:
0.0262
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000356

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
1
-
1
Charlevoix-Saguenay spastic ataxia (2)
-
-
1
Hereditary spastic paraplegia (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.093
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.30
CADD
Uncertain
23
DANN
Uncertain
1.0
DEOGEN2
Benign
0.20
T
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.53
FATHMM_MKL
Uncertain
0.91
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.0077
T
MetaSVM
Benign
-0.38
T
MutationAssessor
Uncertain
2.3
M
PhyloP100
6.0
PrimateAI
Uncertain
0.64
T
PROVEAN
Benign
-0.96
N
REVEL
Uncertain
0.33
Sift
Benign
0.82
T
Sift4G
Pathogenic
0.0
D
Varity_R
0.10
gMVP
0.52
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs11839380;
hg19: chr13-23909142;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.